Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease
Top Cited Papers
- 2 May 2006
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (12), 2554-2560
- https://doi.org/10.1016/j.jacc.2006.04.039
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Inhaled corticosteroids and mortality in chronic obstructive pulmonary diseaseThorax, 2005
- Treatment of stable chronic obstructive pulmonary diseaseThe Lancet, 2004
- Association Between Pulmonary Fibrosis and Coronary Artery DiseaseArchives of Internal Medicine, 2004
- Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatmentProgress in Cardiovascular Diseases, 2003
- Lung Cancer, Cardiopulmonary Mortality, and Long-term Exposure to Fine Particulate Air PollutionJAMA, 2002
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Fine Particulate Air Pollution and Mortality in 20 U.S. Cities, 1987–1994New England Journal of Medicine, 2000
- Pulmonary Function Is a Long-term Predictor of Mortality in the General PopulationChest, 2000
- Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population studyBMJ, 1996
- Lung Function and Risk of Myocardial Infarction and Sudden Cardiac DeathNew England Journal of Medicine, 1976